Contact information
Emma Culver
BSc (Hons), MBChB, MRCP, DPhil
Consultant Hepatologist & Senior Lecturer in Gastroenterology & Hepatology, JR Hospital, Oxford.
- Wellcome Trust Clinical Research Fellow, University of Oxford, Oxford, UK.
Emma Culver is a Consultant Hepatologist and Senior Lecturer at the Translational Gastroenterology Unit, John Radcliffe Hospital in Oxford, with an interest in immune mediated liver diseases including IgG4-related disease, autoimmune hepatitis, primary sclerosing cholangitis and primary biliary cholangitis.
She set up and co-ordinated the IgG4-RD Study in Oxford during her Academic Clinical Fellowship (2010) and Wellcome Trust Clinical Research Fellowship (DPhil 2011-2015). Her PhD work focussed on the natural history and immunological drivers of IgG4-RD. Her NIHR BRC Oxford Clinical Lectureship (2018-) centred on the fibrotic mechanisms of this disease. She runs the Oxford Autoimmune Liver Disease service with specialist IgG4, PSC and autoimmune liver clinics, and runs a regional autoimmune liver disease MDT, and a national Oxford-London IgG4 MDT.
She is Chair of UK IgG4 and on the Steering Committee for UK PSC, and a member of the International IgG4-RD, PSC and AIH Study Groups.
Key publications
-
IMMUNOGLOBULIN E, EOSINOPHILS AND MAST CELLS IN ATOPIC INDIVIDUALS PROVIDE NOVEL INSIGHTS IN IGG4-RELATED DISEASE
Conference paper
Culver EL. et al, (2016), JOURNAL OF HEPATOLOGY, 64, S646 - S646
-
Exposure to occupational antigens might predispose to IgG4-related disease
Journal article
de Buy Wenniger LJM. et al, (2014), Hepatology, 60, 1453 - 1454
-
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis
Journal article
Hart PA. et al, (2013), Gut, 62, 1771 - 1776
-
Evolving role of magnetic resonance techniques in primary sclerosing cholangitis
Journal article
Selvaraj EA. et al, (2019), World Journal of Gastroenterology, 25, 644 - 658
-
Follow‐up magnetic resonance imaging/3D‐magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret
Journal article
Zenouzi R. et al, (2018), Alimentary Pharmacology & Therapeutics, 48, 169 - 178
Recent publications
-
Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin-G4-Related Digestive Disease.
Journal article
Vujasinovic M. et al, (2025), United European gastroenterology journal, 13, 1583 - 1592
-
Inebilizumab for Treatment of IgG4-Related Disease.
Journal article
Stone JH. et al, (2025), The New England journal of medicine, 392, 1168 - 1177
-
Exploring cardiovascular involvement in IgG4-related disease: a case series approach with cardiovascular magnetic resonance
Journal article
Henry JA. et al, (2025), Heart, 111, 133 - 140
-
Enhancing Liver Fibrosis Measurement: Deep Learning and Uncertainty Analysis Across Multi-Centre Cohorts
Preprint
Wojciechowska MK. et al, (2025)
-
Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBD.
Journal article
Motta RV. et al, (2024), Endoscopy international open, 12, E1285 - E1294
